143 related articles for article (PubMed ID: 36627096)
41. Inhibition of MARCH5 ubiquitin ligase abrogates MCL1-dependent resistance to BH3 mimetics via NOXA.
Subramanian A; Andronache A; Li YC; Wade M
Oncotarget; 2016 Mar; 7(13):15986-6002. PubMed ID: 26910119
[TBL] [Abstract][Full Text] [Related]
42. Positional and functional characterisation of apoptosis related genes belonging to the BCL2 family in sheep.
Lyahyai J; Goldammer T; Beattie AE; Zaragoza P; Martín-Burriel I
Cytogenet Genome Res; 2005; 109(4):519-26. PubMed ID: 15905648
[TBL] [Abstract][Full Text] [Related]
43. MCL1 inhibition enhances the therapeutic effect of MEK inhibitors in KRAS-mutant lung adenocarcinoma cells.
Tada M; Sumi T; Tanaka Y; Hirai S; Yamaguchi M; Miyajima M; Niki T; Takahashi H; Watanabe A; Sakuma Y
Lung Cancer; 2019 Jul; 133():88-95. PubMed ID: 31200834
[TBL] [Abstract][Full Text] [Related]
44. Dual inhibition of BCL2L1 and MCL1 is highly effective against RET fusion-positive or MET exon 14 skipping mutation-positive lung adenocarcinoma cells.
Hirai S; Idogawa M; Sumi T; Yamaguchi M; Niki T; Sakuma Y
Biochem Biophys Res Commun; 2022 Nov; 630():24-29. PubMed ID: 36126466
[TBL] [Abstract][Full Text] [Related]
45. Mutated Ptpn11 alters leukemic stem cell frequency and reduces the sensitivity of acute myeloid leukemia cells to Mcl1 inhibition.
Chen L; Chen W; Mysliwski M; Serio J; Ropa J; Abulwerdi FA; Chan RJ; Patel JP; Tallman MS; Paietta E; Melnick A; Levine RL; Abdel-Wahab O; Nikolovska-Coleska Z; Muntean AG
Leukemia; 2015 Jun; 29(6):1290-300. PubMed ID: 25650089
[TBL] [Abstract][Full Text] [Related]
46. MCL1 inhibition is effective against a subset of small-cell lung cancer with high MCL1 and low BCL-X
Yasuda Y; Ozasa H; Kim YH; Yamazoe M; Ajimizu H; Yamamoto Funazo T; Nomizo T; Tsuji T; Yoshida H; Sakamori Y; Nakajima N; Menju T; Yoshizawa A; Date H; Hirai T
Cell Death Dis; 2020 Mar; 11(3):177. PubMed ID: 32152266
[TBL] [Abstract][Full Text] [Related]
47. Obatoclax overcomes resistance to cell death in aggressive thyroid carcinomas by countering Bcl2a1 and Mcl1 overexpression.
Champa D; Russo MA; Liao XH; Refetoff S; Ghossein RA; Di Cristofano A
Endocr Relat Cancer; 2014 Oct; 21(5):755-67. PubMed ID: 25012986
[TBL] [Abstract][Full Text] [Related]
48. Myeloid cell leukemia-1 is an important apoptotic survival factor in triple-negative breast cancer.
Goodwin CM; Rossanese OW; Olejniczak ET; Fesik SW
Cell Death Differ; 2015 Dec; 22(12):2098-106. PubMed ID: 26045046
[TBL] [Abstract][Full Text] [Related]
49. γ-Secretase inhibition promotes cell death, Noxa upregulation, and sensitization to BH3 mimetic ABT-737 in human breast cancer cells.
Séveno C; Loussouarn D; Bréchet S; Campone M; Juin P; Barillé-Nion S
Breast Cancer Res; 2012 Jun; 14(3):R96. PubMed ID: 22703841
[TBL] [Abstract][Full Text] [Related]
50. MCL1 nuclear translocation induces chemoresistance in colorectal carcinoma.
Fu D; Pfannenstiel L; Demelash A; Phoon YP; Mayell C; Cabrera C; Liu C; Zhao J; Dermawan J; Patil D; DeVecchio J; Kalady M; Souers AJ; Phillips DC; Li X; Gastman B
Cell Death Dis; 2022 Jan; 13(1):63. PubMed ID: 35042842
[TBL] [Abstract][Full Text] [Related]
51. Noxa upregulation and 5-gene apoptotic biomarker panel in colorectal cancer.
Kosmidou V; Vlassi M; Anagiotos K; Raftopoulou S; Kalogerakou E; Skarmalioraki S; Aggeli C; Choreftaki T; Zografos G; Pintzas A
Eur J Clin Invest; 2021 Jan; 51(1):e13353. PubMed ID: 32682341
[TBL] [Abstract][Full Text] [Related]
52. Sensitivity to splicing modulation of BCL2 family genes defines cancer therapeutic strategies for splicing modulators.
Aird D; Teng T; Huang CL; Pazolli E; Banka D; Cheung-Ong K; Eifert C; Furman C; Wu ZJ; Seiler M; Buonamici S; Fekkes P; Karr C; Palacino J; Park E; Smith PG; Yu L; Mizui Y; Warmuth M; Chicas A; Corson L; Zhu P
Nat Commun; 2019 Jan; 10(1):137. PubMed ID: 30635584
[TBL] [Abstract][Full Text] [Related]
53. MCL1 binding to the reverse BH3 motif of P18INK4C couples cell survival to cell proliferation.
Whitaker RH; Placzek WJ
Cell Death Dis; 2020 Feb; 11(2):156. PubMed ID: 32111816
[TBL] [Abstract][Full Text] [Related]
54. CDK7 inhibitor THZ1 inhibits MCL1 synthesis and drives cholangiocarcinoma apoptosis in combination with BCL2/BCL-XL inhibitor ABT-263.
Huang T; Ding X; Xu G; Chen G; Cao Y; Peng C; Shen S; Lv Y; Wang L; Zou X
Cell Death Dis; 2019 Aug; 10(8):602. PubMed ID: 31399555
[TBL] [Abstract][Full Text] [Related]
55. The anti-apoptotic protein BCL2L1/Bcl-xL is neutralized by pro-apoptotic PMAIP1/Noxa in neuroblastoma, thereby determining bortezomib sensitivity independent of prosurvival MCL1 expression.
Hagenbuchner J; Ausserlechner MJ; Porto V; David R; Meister B; Bodner M; Villunger A; Geiger K; Obexer P
J Biol Chem; 2010 Mar; 285(10):6904-12. PubMed ID: 20051518
[TBL] [Abstract][Full Text] [Related]
56. MCL1 Is Required for Maintenance of Intestinal Homeostasis and Prevention of Carcinogenesis in Mice.
Healy ME; Boege Y; Hodder MC; Böhm F; Malehmir M; Scherr AL; Jetzer J; Chan LK; Parrotta R; Jacobs K; Clerbaux LA; Kreutzer S; Campbell A; Gilchrist E; Gilroy K; Rodewald AK; Honcharova-Biletska H; Schimmer R; Vélez K; Büeler S; Cammareri P; Kalna G; Wenning AS; McCoy KD; Gomez de Agüero M; Schulze-Bergkamen H; Klose CSN; Unger K; Macpherson AJ; Moor AE; Köhler B; Sansom OJ; Heikenwälder M; Weber A
Gastroenterology; 2020 Jul; 159(1):183-199. PubMed ID: 32179094
[TBL] [Abstract][Full Text] [Related]
57. Inhibiting the expression of anti-apoptotic genes BCL2L1 and MCL1, and apoptosis induction in glioblastoma cells by microRNA-342.
Ghaemi S; Arefian E; Rezazadeh Valojerdi R; Soleimani M; Moradimotlagh A; Jamshidi Adegani F
Biomed Pharmacother; 2020 Jan; 121():109641. PubMed ID: 31751869
[TBL] [Abstract][Full Text] [Related]
58. PIM1 kinase regulates cell death, tumor growth and chemotherapy response in triple-negative breast cancer.
Brasó-Maristany F; Filosto S; Catchpole S; Marlow R; Quist J; Francesch-Domenech E; Plumb DA; Zakka L; Gazinska P; Liccardi G; Meier P; Gris-Oliver A; Cheang MC; Perdrix-Rosell A; Shafat M; Noël E; Patel N; McEachern K; Scaltriti M; Castel P; Noor F; Buus R; Mathew S; Watkins J; Serra V; Marra P; Grigoriadis A; Tutt AN
Nat Med; 2016 Nov; 22(11):1303-1313. PubMed ID: 27775704
[TBL] [Abstract][Full Text] [Related]
59. BCL2 Regulation according to Molecular Subtype of Breast Cancer by Analysis of The Cancer Genome Atlas Database.
Hwang KT; Kim K; Chang JH; Oh S; Kim YA; Lee JY; Jung SH; Choi IS
Cancer Res Treat; 2018 Jul; 50(3):658-669. PubMed ID: 28701032
[TBL] [Abstract][Full Text] [Related]
60. miR-509-3p promotes cisplatin-induced apoptosis in ovarian cancer cells through the regulation of anti-apoptotic genes.
Chen W; Du J; Li X; Su J; Huang Y; Ding N; Zhang M; Jiang S
Pharmacogenomics; 2017 Dec; 18(18):1671-1682. PubMed ID: 29173002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
